These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35789450)

  • 1. In silico identification and in vitro antiviral validation of potential inhibitors against Chikungunya virus.
    Verma J; Hasan A; Sunil S; Subbarao N
    J Comput Aided Mol Des; 2022 Jul; 36(7):521-536. PubMed ID: 35789450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico identification of small molecule protein-protein interaction inhibitors: targeting hotspot regions at the interface of MXRA8 and CHIKV envelope protein.
    Verma J; Subbarao N
    J Biomol Struct Dyn; 2023 May; 41(8):3349-3367. PubMed ID: 35272566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suramin Inhibits Chikungunya Virus Entry and Transmission.
    Ho YJ; Wang YM; Lu JW; Wu TY; Lin LI; Kuo SC; Lin CC
    PLoS One; 2015; 10(7):e0133511. PubMed ID: 26208101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus.
    Souza BG; Choudhary S; Vilela GG; Passos GFS; Costa CACB; Freitas JD; Coelho GL; Brandão JA; Anderson L; Bassi ÊJ; Araújo-Júnior JX; Tomar S; Silva-Júnior EFD
    Eur J Med Chem; 2023 Oct; 258():115572. PubMed ID: 37364511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a Potent and Selective Chikungunya Virus Envelope Protein Inhibitor through Computer-Aided Drug Design.
    Battini L; Fidalgo DM; Álvarez DE; Bollini M
    ACS Infect Dis; 2021 Jun; 7(6):1503-1518. PubMed ID: 34048233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
    Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
    Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K
    Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethyl palmitate, an anti-chikungunya virus principle from Sauropus androgynus, a medicinal plant used to alleviate fever in ethnomedicine.
    Sagna A; Nair RVR; Hulyalkar N; Rajasekharan S; Nair VTG; Sivakumar KC; Suja SR; Baby S; Sreekumar E
    J Ethnopharmacol; 2023 Jun; 309():116366. PubMed ID: 36914036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of Chikungunya Virus Cell Entry Unraveled by Single-Virus Tracking in Living Cells.
    Hoornweg TE; van Duijl-Richter MKS; Ayala Nuñez NV; Albulescu IC; van Hemert MJ; Smit JM
    J Virol; 2016 May; 90(9):4745-4756. PubMed ID: 26912616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission.
    Wang YM; Lu JW; Lin CC; Chin YF; Wu TY; Lin LI; Lai ZZ; Kuo SC; Ho YJ
    Antiviral Res; 2016 Nov; 135():81-90. PubMed ID: 27742486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Explorations on the antiviral potential of zinc and magnesium salts against chikungunya virus: implications for therapeutics.
    Davuluri KS; Shukla S; Kakade M; Cherian S; Alagarasu K; Parashar D
    Front Cell Infect Microbiol; 2024; 14():1335189. PubMed ID: 38895735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.
    Fong RH; Banik SS; Mattia K; Barnes T; Tucker D; Liss N; Lu K; Selvarajah S; Srinivasan S; Mabila M; Miller A; Muench MO; Michault A; Rucker JB; Paes C; Simmons G; Kahle KM; Doranz BJ
    J Virol; 2014 Dec; 88(24):14364-79. PubMed ID: 25275138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico and in vitro evaluation of silibinin: a promising anti-Chikungunya agent.
    Dutta SK; Sengupta S; Tripathi A
    In Vitro Cell Dev Biol Anim; 2022 Mar; 58(3):255-267. PubMed ID: 35381943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arctigenin from Arctium lappa L. inhibits chikungunya virus by affecting its entry and replication.
    Shukla S; Kakade M; Cherian S; Alagarasu K; Parashar D
    Phytomedicine; 2024 Jun; 128():155491. PubMed ID: 38489894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents.
    Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Chikungunya Virus Variants at the E1-E1 Interglycoprotein Spike Interface Impact Virus Attachment and Inflammation.
    Rangel MV; McAllister N; Dancel-Manning K; Noval MG; Silva LA; Stapleford KA
    J Virol; 2022 Feb; 96(4):e0158621. PubMed ID: 34935436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.
    Silva LA; Khomandiak S; Ashbrook AW; Weller R; Heise MT; Morrison TE; Dermody TS
    J Virol; 2014 Mar; 88(5):2385-97. PubMed ID: 24371059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Peptide Binders to Truncated Recombinant Chikungunya Virus Envelope Protein 2 Using Phage Display Technology and Their
    Agarwal G; Gabrani R
    Protein Pept Lett; 2021; 28(5):508-519. PubMed ID: 33121397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
    Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R
    Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.